// Imugene Announces Presentation on HER-Vaxx Cancer Vaccine at the American Association for Cancer Research 2019 Annual Meeting - Finance News Network Skip to main content

New multispecialty org launches to support independent practice

Image
st joseph family practice :: Article Creator St. Joseph County Health Alert: Gas Stoves Linked To Asthma In Children And Early Deaths. Doctor Explains State Zip Code Country St. Joseph County Residents: THC Lingers In Breastmilk For Days. Doctor Explains State Zip Code Country Second Pop-up Pap Test Clinic To Be Held May 10 At St. Joseph's Breadcrumb Trail Links News Local News For the most part, women look forward to having a pap test as much as they, well, look forward to having a pap test. Published May 02, 2024  •  Last updated May 03, 2024  •  3 minute read Join the conversation You can save this article by registering for free here. Or sign-in if you have an account. St. Joseph's Health Care London on Grosvenor Street in London. Photograph taken on Monday, June 5, 2023. (Mike Hensen/The London Free Press) Article content For the most part, women look forward to having a pap

Imugene Announces Presentation on HER-Vaxx Cancer Vaccine at the American Association for Cancer Research 2019 Annual Meeting - Finance News Network

Media ReleasesImugene Limited

SYDNEY, Australia, 28 February 2019: Imugene Limited (ASX:IMU), a clinical stage immuno-oncology company, today announced Professor Ursula Wiedermann will present on the HER-Vaxx cancer vaccine at the American Association for Cancer Research (AACR) 2019 Annual Meeting.

The poster (abstract number 8249) will be presented by Prof Wiedermann, the co-inventor of the HER-Vaxx cancer vaccine and member of the Company’s Scientific Advisory Board, at the AACR Annual Meeting in Atlanta, Georgia scheduled for March 29 to April 3, 2019.

The abstract presentation is entitled ‘A Phase Ib open label multicenter study with a HER2/neu peptide vaccine administered with cisplatin and 5-fluorouracil or capecitabine chemotherapy shows safety, immunogenicity and clinical response in patients with HER2/Neu overexpressing advanced cancer of the stomach.’

For further information please download PDF attached: Download this document



https://ift.tt/2C6RYzt

Comments

Popular posts from this blog

Observership Program listings for international medical graduates

Vaccination Sites | Covid-19

Vaccination Sites | Covid-19